Stock Ratings / Health Care / ATPC / insiders

CCM (22) DCGO (41) PIII (24) BMGL (53) ⌘ Pro Terminal →

Agape ATP Corporation (ATPC) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$1.45 -10.22% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.42

Agape ATP Corporation (ATPC) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $1.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ATPC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ATPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Agape ATP Corporation (NASDAQ: ATPC) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $1.45 (-10.22% 1D, market cap $1.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATPC ranks #569 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ATPC compare to CCM and DCGO in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), ATPC carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of 55.0%, and ROIC of -11.5%. By comparison, CCM (Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)) holds a E grade (22/100 RQD, P/E N/A, ROIC -35.0%, cap $15.9M) and DCGO (DocGo Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $27.0M). Among the 5-stock peer group, ATPC leads on earnings multiple (N/A) while ATPC leads on capital efficiency (-11.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ATPC?

▼

Per ATPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001713210), Agape ATP Corporation generated $1.5M in revenue (+15.2% YoY), -$2.3M in net income, and -$2.4M in free cash flow against $24.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.42 (-2.03%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-8.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ATPC)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (39/100 Composite)

🔍 WHY ATPC SCORES 39/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (28% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+11/20 pts (28% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 33.2 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$2.22-29.3% Next Q

Q2 (-2Q)

Grade D$1.57-11.5% Next Q

Q3 (-1Q)

Grade D$1.39+4.3% Next Q

Current

Grade D-$1.45-7.6% Hist 90D α

Trajectory: D (47) → D- (39)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ATPC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ATPC currently carries a cautious 39/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.07) and Max Pain ($1.52) forces dealer call-delta covering toward $77.17.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATPC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ATPC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 39%NO 61%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

ATPC Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ATPC)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ATPC. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ATPC)

✓Walkthrough of ATPC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ATPC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -34.98%🛡️ HOLDING TREND SUPPORT

2026-10-30O $1.54H $1.56L $1.45C $1.45VOL 15.8K

RES: $2.99SUP: $1.23SMA50: $2.07SMA200: $2.66

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ATPC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ATPC Butterfly Map → + Track ATPC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +15.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ATPC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ATPC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ATPC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATPC)

Health Care Rank #569 of 1016 ⚔️ CCM vs ATPC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ATPC vs. CCM, DCGO, PIII, BMGL)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Agape ATP Corporation (ATPC) ranks #569 by composite RQD confidence (39/100, grade D-) and #1008 by equity capitalization ($1.6M). Within this direct 5-issuer industry benchmark cohort, ATPC leads on earnings valuation at N/A trailing P/E, while ATPC leads on capital efficiency and profitability with -11.5% ROIC and 55.0% gross margin. BMGL currently holds the highest overall quantitative score in the immediate peer group at 53/100 (D+) compared with ATPC at 39/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ATPC ACTIVE Agape ATP Corporation	D-	39/100	—	55.0%	-11.5%	-10.22%	$1.6M	Benchmark Subject
CCM Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)	E	22/100	—	5.7%	-35.0%	-2.46%	$15.9M	/ccm-vs-atpc →
DCGO DocGo Inc.	D-	41/100	—	—	-35.0%	-9.59%	$27.0M	/dcgo-vs-atpc →
PIII P3 Health Partners Inc. (Class A)	E	24/100	—	—	-35.0%	-4.05%	$30.5M	/piii-vs-atpc →
BMGL Basel Medical Group Ltd	D+	53/100	—	—	—	+6.11%	$36.0M	/bmgl-vs-atpc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001713210

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Agape ATP Corporation (ATPC) reported GAAP revenue of $1.5M (+15.2% vs. FY2024 revenue of $1.3M , and +6.5% cumulative change since FY2023) , GAAP net income of -$2.3M, operating cash flow of -$2.4M, and free cash flow of -$2.4M (+11.5% YoY). On the balance sheet, ATPC closed FY2025 with $24.6M in total assets against $0 in total debt (Altman Z-Score: 0.49, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.5M	-$2.3M	-$2.4M	-$2.4M	$24.6M	—
FY2024 (FY)	2024-12-31	$1.3M	-$2.5M	-$2.7M	-$2.7M	$3.2M	—
FY2023 (FY)	2023-12-31	$1.4M	-$2.1M	-$2.0M	-$2.0M	—	—

3. ATPC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ATPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ATPC compare to CCM and DCGO in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ATPC?

Where is ATPC trading relative to its 50-day, 200-day, and 52-week technical levels?

ATPC last traded at $1.45 (-10.22% on volume of 16,025 shares), positioning the stock -29.95% below its 50-day simple moving average ($2.07) and -45.49% below its 200-day simple moving average ($2.66). Across its 52-week range of $1.31 to $73.50, ATPC sits at the 0.2% percentile with a 14-day RSI of 33.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.27 to $1.63).

ATPC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are ATPC insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies ATPC leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: ATPC RQD Cockpit ATPC 12M Forecast ATPC Earnings & Move ATPC Dividends & DRIP ATPC Insiders & 13F ATPC Whale Options ATPC Profit Sankey ATPC News & Why

ROARABLE RATING BRIEF • RQD 39/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

ATPC — Agape ATP Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:54:54Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, ATPC scores 39 out of 100, grade D-, with the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:

Fundamental Cash Engine (4 / 20): Per the Roarable RQD rating, ROIC is -11.5% and FCF yield is 0%. The company is not currently generating returns on capital or free cash flow to offset its losses. For a prospective investor, this removes the cash-flow floor that often supports valuation in micro-cap names.
Whale 13F Flow (11 / 20): Per the Roarable RQD rating, institutional accumulation and options positioning are scored at a moderate level. The pillar summary does not provide holder-level detail, so the direction of institutional flow cannot be confirmed from the data here.
Insider Conviction (5 / 20): Per the Roarable RQD rating, SEC Form 4 and Congressional PTR cluster flow are weak. Limited insider conviction means management is not signaling confidence through open-market activity, per the rating.
Macro Regime Fit (11 / 20): Per the Roarable RQD rating, beta is 1.0 with moderate sector sensitivity. The stock is not defensively positioned against broad market moves, and its recent price action (-10.49% on the day) reflects that exposure.
Forensic Balance Sheet (8 / 20): Per the Roarable RQD rating, Altman Z is 0.49, Piotroski F is 4/9, and Debt/Equity is 0.5. The Altman Z reading sits in a distress-range territory, which is the core reason this pillar is weak.

Investor implications: The upside case rests on a turnaround in operating margins from -60% toward breakeven, which the data does not show as underway. The valuation tradeoff is that with no positive earnings (P/E not available in source data) and a market cap of $1.6M against a 52-week range of $1.31 - $73.5, the stock has already experienced severe price compression. The second-order risk is financing: with cash at $0.1M in FY 2025 and FCF of $-2.4M, the company's ability to fund operations without dilution or new capital is a central open question.

Business

Agape ATP Corporation (ATPC) is a NASDAQ-listed issuer in the Health Care sector, Medical/Nursing Services industry. Per the company profile, its market capitalization is $0.0B. Per the SEC financials, the company reported revenue of $1.5M for FY 2025, with gross margin of 55% per the market data. The source data does not describe the specific products or services sold, its customer base, or its monetization model beyond these figures.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$1.5M	$-3.3M	$-2.3M	N/A	$-2.4M	$0.1M	N/A
FY 2024	$1.3M	$-2.6M	$-2.5M	N/A	$-2.7M	$2.0M	N/A
FY 2023	$1.4M	$-2.1M	$-2.1M	N/A	$-2.0M	N/A	N/A

Per the SEC financials, the company has reported operating losses in each period shown, with operating margin at -60% and net margin at -60% per the market data. Per the Roarable RQD rating, ROIC is -11.5%. Altman Z is 0.49 and Piotroski F is 4/9 per the forensic balance sheet pillar. Cash declined from $2.0M in FY 2024 to $0.1M in FY 2025, and FCF has been negative across all three reported periods.

Recent Catalysts & News Wire Analysis

The news feed contains six items, all referencing ATPC, with no specific operational catalyst described in the summaries. Items are generic aggregator or market-wire entries (TradingView, Yahoo Finance UK, Yahoo! Finance Canada) and one reference to an earnings report.

Market Wire (YELLOW): Multiple items labeled MARKET WIRE carry a YELLOW light, indicating neutral-to-cautionary attention but no specific event.
Risk Watch (RED): One item, an earnings-related headline titled "ATPC Q4 2024 Earnings: Reported Loss of $0.20 per Share as Stock Slips 6.36%," is flagged RISK WATCH with a RED light. Its summary text is not a meaningful description of the company and appears to be a misattributed source reference, so the earnings figure should be verified against primary filings.
The Butterfly Supply-Chain Graph shows no supply-chain links and no proprietary signals.

Open Questions

What is the company's specific product or service mix, and what drives its $1.5M revenue base?
How does the company intend to fund operations given $0.1M cash and $-2.4M FCF in FY 2025?
What explains the 52-week range of $1.31 - $73.5, and is there a recent corporate event behind it?
Does the Q4 2024 earnings headline (loss of $0.20 per share) reconcile with the reported financials, and what is the correct EPS?
What is the debt position, since the source data reports debt as N/A for every period?

ATPC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Agape ATP Corporation (ATPC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ATPC Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 6h ago

Agape ATP Corporation Estimates – NASDAQ:ATPC

TradingView report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 9h ago

BranchOut Food Inc. (BOF) stock price, news, quote and history

Yahoo Finance UK report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 12h ago

AXIL Brands, Inc. (AXIL) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH https://www.dars.gov.et/ • 15h ago

ATPC Q4 2024 Earnings: Reported Loss of $0.20 per Share as Stock Slips 6.36% - Investor Earnings Call

https://www.dars.gov.et/ report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 18h ago

Stratum Holdings Corp. (SRTM) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 21h ago

SRX Global Inc. (SRXH) stock price, news, quote and history

Yahoo Finance UK report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance Singapore • 1d ago

SRX Global Inc. (SRXH) interactive stock chart – Yahoo Finance

Yahoo Finance Singapore report covering Agape ATP Corporation (ATPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 21d ago

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings (NASDAQ:ITOC) shares

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ATPC Bull vs. Bear Conversation Board — What's Your Call at $1.45?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ATPC 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.28 (-11.7%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is ATPC (D- • RQD 39/100) a Buy at $1.45?

Welcome to the ATPC (Agape ATP Corporation) Roar Pit. Current RQD Composite is 39/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Medical/Nursing Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.19 (-17.9%)

Spot @ $1.45

Pump the brakes on ATPC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ATPC, but look at what you are paying: current EV/EBITDA multiples with 55.0% gross margins. Unless Agape ATP Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.68 (+15.9%)

Spot @ $1.45

ATPC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ATPC, the market is fixating on short-term headline noise in Medical/Nursing Services and ignoring the balance sheet and cash flow trajectory. At $1.45 (52-wk range $1.31 - $73.50), any beat on forward guidance forces shorts and underweight funds to chase.